NCT00787358View on ClinicalTrials.gov

A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women

PHASE2WithdrawnINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions

Hip Fracture

Interventions

DRUG

ZT-031

80 ul subcutaneous injection per day

OTHER

placebo

80 ul daily subcutaneous injection of vehicle only

Trial Locations (1)

14642

J. Edward Puzas, Rochester

Sponsors

Lead Sponsor

Zelos Therapeutics

All Listed Sponsors

lead

Zelos Therapeutics

INDUSTRY

NCT00787358 - A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women | Biotech Hunter | Biotech Hunter